FDA-Device2023-07-05Class II

NaviCare Patient Safety V3.9.200 to 3.9.600, used with the Centrella Bed

Baxter Healthcare Corporation
Hazard

Baxter identified a potential risk where the "safety" monitoring and "bed exit" monitoring features may enter a permanent state of alert suppression. In this state, a caregiver may not be alerted remotely when assigned patient protocols (bed exit, siderail position, brakes off, height of bed changes, head of bed angle, and/or turn reminders) are turned off.

Sold states
US Nationwide distribution in the states of OR, SC, VA, TN, GA, NC, CO, NC, FL.
Affected count
7 software versions
Manufactured in
1 Baxter Pkwy, N/A, Deerfield, IL, United States
Products
NaviCare Patient Safety V3.9.200 to 3.9.600, used with the Centrella Bed

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2007-2023

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief